LIPO (Lipella Pharmaceuticals) Total Operating Expense: $2.38 Mil (TTM As of Sep. 2025)


What is Lipella Pharmaceuticals Total Operating Expense?

Lipella Pharmaceuticals LIPO -35.56% Total Operating Expense is $2.38 Mil as of Sep. 2025. The stock has 1 warning sign investors should review.

Lipella Pharmaceuticals's Total Operating Expense for the three months ended in Sep. 2025 was $0.55 Mil. Lipella Pharmaceuticals's Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2025 was $2.38 Mil.

Lipella Pharmaceuticals Total Operating Expense Related Terms

Lipella Pharmaceuticals Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Lipella Pharmaceuticals's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lipella Pharmaceuticals Total Operating Expense Chart

Lipella Pharmaceuticals Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Total Operating Expense
0.04 0.72 0.23 2.16 2.00

Lipella Pharmaceuticals Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.41 0.93 0.34 0.57 0.55

Lipella Pharmaceuticals Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.38 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $2.38 Mil mean?
Lipella Pharmaceuticals (LIPO) has a Total Operating Expense of $2.38 Mil as of Sep. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Lipella Pharmaceuticals and its competitors.
Is Lipella Pharmaceuticals' Total Operating Expense too high?
Lipella Pharmaceuticals' current Total Operating Expense is $2.38 Mil.
How does Lipella Pharmaceuticals' Total Operating Expense compare to IOBTQ and WINT?
Lipella Pharmaceuticals' Total Operating Expense of $2.38 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Lipella Pharmaceuticals and its competitors. Lipella Pharmaceuticals's current Total Operating Expense is $2.38 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lipella Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Lipella Pharmaceuticals (LIPO) is currently considered Possible Value Trap. The stock's GF Value™ is $8.67, compared to a current price of $0.06 — trading 99.3% below its estimated fair value. The current Total Operating Expense is $2.38 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Lipella Pharmaceuticals (LIPO), the current Total Operating Expense is $2.38 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lipella Pharmaceuticals Business Description

Address 7800 Susquehanna Street, Suite 505, Pittsburgh, PA, USA, 15208
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410, which can be helpful in the treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.